Swapnil Hiremath 🍁🇨🇦
The @thelancet.com review on global BP control www.thelancet.com/journals/lan... Worsening BP control in Canada www.sciencedirect.com/science/arti... Improving BP control in US from @amjhypertension.bsky.social academic.oup.com/ajh/article/... #Hypertension #WorldHypertensionDay

Global and national high blood...
The Lancet (@thelancet.bsky.social)

Welcome to The Lancet, one of the world’s leading medical journals, published weekly since 1823. 🌐 thelancet.com

Bluesky Social
May 22, 2025 at 1:17pmWeb
Show threadSwapnil Hiremath 🍁🇨🇦May 22, 2025
even in advanced CKD - starting RASi is beneficial www.nephjc.com/news/aceing-... (note they were mostly proteinuric and DM) #WorldHypertensionDay
ACEing the management of advanced CKD — NephJC

This week we come to meta-analyse, strikingly late, the cornerstone of all CKD treatments. Are you still in doubt? We need ACEing CKD to the end of GFR, and beyond

NephJC
Show threadSwapnil Hiremath 🍁🇨🇦May 22, 2025
BP Targets: the @kdigo.org www.nephjc.com/news/kdigo-bp The ESPRIT trial discussion www.nephjc.com/news/esprit The BPROAD discussion www.nephjc.com/news/bproad #WorldHypertensionDay #120ForAll

The KDIGO 2021 BP Guidelines ...
KDIGO (@kdigo.org)

Global Science: Local Change. Advancing kidney health worldwide through evidence-based guidelines, collaboration, and innovation. Follow us for the latest updates and resources from KDIGO.

Bluesky Social
Show threadSwapnil Hiremath 🍁🇨🇦May 22, 2025
the amiloride - spironolactone RCT jamanetwork.com/journals/jam... PATHWAY-2 trial www.thelancet.com/article/S014... Lorundrostat RCT www.nejm.org/doi/full/10.... (coming on #NephJC soon) #WorldHypertensionDay

Spironolactone vs Amiloride fo...
Show threadSwapnil Hiremath 🍁🇨🇦May 22, 2025
longer discussion including MRAs and ASIs here www.nephjc.com/news/2024/10... #WorldHypertensionDay

Finerenone Finally Finishing o...
Finerenone Finally Finishing off Spironolactone? — NephJC

A commentary putting the recent finerenone and spironolactone trials in perspective

NephJC
Show threadSwapnil Hiremath 🍁🇨🇦May 22, 2025
little renal denervation data in dialysis - summarized here pmc.ncbi.nlm.nih.gov/articles/PMC... my comment on RDN in general here pubmed.ncbi.nlm.nih.gov/39899875/ Patient preference studies here: pubmed.ncbi.nlm.nih.gov/32773653/ pubmed.ncbi.nlm.nih.gov/36484251/ #WorldHypertensionDay

Renal Denervation in End-Stage...
Renal Denervation in End-Stage Renal Disease: Current Evidence and Perspectives

In patients with end-stage renal disease (ESRD) undergoing haemodialysis, hypertension is of common detection and frequently inadequately controlled. Multiple pathophysiological mechanisms are involved in the development and progression of the ...

PubMed Central (PMC)
Show threadSwapnil Hiremath 🍁🇨🇦May 22, 2025
K issues #NephJC www.nephjc.com/news/salt-su... Podcast www.nephjc.com/freelyfilter... K switch mechanism pubmed.ncbi.nlm.nih.gov/38081406/ in @ajkd.bsky.social pubmed.ncbi.nlm.nih.gov/37772757/ from @amjhypertension.bsky.social journals.physiology.org/doi/full/10.... #WorldHypertensionDay

The Na-K Exchange Saves Lives ...
Bluesky

Bluesky Social
Show threadSwapnil Hiremath 🍁🇨🇦May 22, 2025
The ARNI data in CKD here pubmed.ncbi.nlm.nih.gov/30002098/ #WorldHypertensionDay

Effects of Sacubitril/Valsarta...
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease - PubMed

URL: http://www.isrctn.com . Unique identifier: ISRCTN11958993.

PubMed